nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoniazid—CYP2A6—lung cancer	0.268	0.585	CbGaD
Isoniazid—CYP2E1—lung cancer	0.19	0.415	CbGaD
Isoniazid—CYP2C19—Gefitinib—lung cancer	0.0247	0.0714	CbGbCtD
Isoniazid—CYP2C19—Teniposide—lung cancer	0.024	0.0693	CbGbCtD
Isoniazid—CYP2C9—Gefitinib—lung cancer	0.0206	0.0594	CbGbCtD
Isoniazid—CYP2C9—Teniposide—lung cancer	0.0199	0.0576	CbGbCtD
Isoniazid—CYP2D6—Gefitinib—lung cancer	0.0188	0.0543	CbGbCtD
Isoniazid—CYP2C8—Erlotinib—lung cancer	0.0174	0.0503	CbGbCtD
Isoniazid—CYP2E1—Etoposide—lung cancer	0.0169	0.0487	CbGbCtD
Isoniazid—CYP2C8—Paclitaxel—lung cancer	0.016	0.0461	CbGbCtD
Isoniazid—CYP2D6—Vinorelbine—lung cancer	0.0145	0.0418	CbGbCtD
Isoniazid—CYP1A2—Erlotinib—lung cancer	0.0135	0.039	CbGbCtD
Isoniazid—CYP3A4—Topotecan—lung cancer	0.0131	0.0378	CbGbCtD
Isoniazid—CYP2C8—Etoposide—lung cancer	0.0126	0.0364	CbGbCtD
Isoniazid—CYP3A4—Gefitinib—lung cancer	0.012	0.0345	CbGbCtD
Isoniazid—CYP3A4—Teniposide—lung cancer	0.0116	0.0335	CbGbCtD
Isoniazid—CYP2C9—Paclitaxel—lung cancer	0.0111	0.0321	CbGbCtD
Isoniazid—CYP2D6—Erlotinib—lung cancer	0.0111	0.0321	CbGbCtD
Isoniazid—CYP1A2—Etoposide—lung cancer	0.00976	0.0282	CbGbCtD
Isoniazid—CYP3A4—Vinorelbine—lung cancer	0.00921	0.0266	CbGbCtD
Isoniazid—CYP2C9—Cisplatin—lung cancer	0.00895	0.0258	CbGbCtD
Isoniazid—CYP2D6—Vinblastine—lung cancer	0.00893	0.0258	CbGbCtD
Isoniazid—CYP3A4—Crizotinib—lung cancer	0.00733	0.0212	CbGbCtD
Isoniazid—CYP3A4—Erlotinib—lung cancer	0.00707	0.0204	CbGbCtD
Isoniazid—CYP3A4—Paclitaxel—lung cancer	0.00647	0.0187	CbGbCtD
Isoniazid—CYP3A4—Irinotecan—lung cancer	0.00639	0.0184	CbGbCtD
Isoniazid—CYP3A4—Vinblastine—lung cancer	0.00568	0.0164	CbGbCtD
Isoniazid—CYP2D6—Doxorubicin—lung cancer	0.00549	0.0158	CbGbCtD
Isoniazid—CYP3A4—Etoposide—lung cancer	0.00511	0.0148	CbGbCtD
Isoniazid—CYP3A4—Docetaxel—lung cancer	0.00468	0.0135	CbGbCtD
Isoniazid—CYP3A4—Doxorubicin—lung cancer	0.00349	0.0101	CbGbCtD
Isoniazid—Agranulocytosis—Vinorelbine—lung cancer	0.000354	0.00346	CcSEcCtD
Isoniazid—Hypersensitivity—Pemetrexed—lung cancer	0.000347	0.00339	CcSEcCtD
Isoniazid—Hypersensitivity—Gefitinib—lung cancer	0.000344	0.00337	CcSEcCtD
Isoniazid—Asthenia—Pemetrexed—lung cancer	0.000338	0.0033	CcSEcCtD
Isoniazid—Asthenia—Gefitinib—lung cancer	0.000335	0.00328	CcSEcCtD
Isoniazid—Decreased appetite—Teniposide—lung cancer	0.000331	0.00324	CcSEcCtD
Isoniazid—Ill-defined disorder—Vinblastine—lung cancer	0.000331	0.00323	CcSEcCtD
Isoniazid—Vomiting—Crizotinib—lung cancer	0.000327	0.0032	CcSEcCtD
Isoniazid—Rash—Crizotinib—lung cancer	0.000325	0.00317	CcSEcCtD
Isoniazid—Neuritis—Doxorubicin—lung cancer	0.000323	0.00316	CcSEcCtD
Isoniazid—Malaise—Vinblastine—lung cancer	0.000321	0.00314	CcSEcCtD
Isoniazid—Ill-defined disorder—Topotecan—lung cancer	0.000321	0.00314	CcSEcCtD
Isoniazid—Feeling abnormal—Teniposide—lung cancer	0.000314	0.00307	CcSEcCtD
Isoniazid—Malaise—Topotecan—lung cancer	0.000312	0.00305	CcSEcCtD
Isoniazid—Convulsion—Vinblastine—lung cancer	0.000309	0.00302	CcSEcCtD
Isoniazid—Hyperglycaemia—Gemcitabine—lung cancer	0.000308	0.00301	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Methotrexate—lung cancer	0.000306	0.00299	CcSEcCtD
Isoniazid—Nausea—Crizotinib—lung cancer	0.000306	0.00299	CcSEcCtD
Isoniazid—Jaundice—Irinotecan—lung cancer	0.000305	0.00298	CcSEcCtD
Isoniazid—Body temperature increased—Teniposide—lung cancer	0.000301	0.00295	CcSEcCtD
Isoniazid—Discomfort—Vinblastine—lung cancer	0.0003	0.00293	CcSEcCtD
Isoniazid—Vomiting—Pemetrexed—lung cancer	0.000299	0.00293	CcSEcCtD
Isoniazid—Neuropathy peripheral—Gemcitabine—lung cancer	0.000298	0.00292	CcSEcCtD
Isoniazid—Vomiting—Gefitinib—lung cancer	0.000297	0.00291	CcSEcCtD
Isoniazid—Rash—Pemetrexed—lung cancer	0.000297	0.0029	CcSEcCtD
Isoniazid—Rash—Gefitinib—lung cancer	0.000295	0.00288	CcSEcCtD
Isoniazid—Discomfort—Topotecan—lung cancer	0.000291	0.00285	CcSEcCtD
Isoniazid—Liver injury—Doxorubicin—lung cancer	0.000286	0.0028	CcSEcCtD
Isoniazid—Vasculitis—Methotrexate—lung cancer	0.000285	0.00279	CcSEcCtD
Isoniazid—Thrombocytopenia—Vinblastine—lung cancer	0.000285	0.00278	CcSEcCtD
Isoniazid—Agranulocytosis—Gemcitabine—lung cancer	0.000284	0.00278	CcSEcCtD
Isoniazid—Hypersensitivity—Teniposide—lung cancer	0.000281	0.00275	CcSEcCtD
Isoniazid—Nausea—Pemetrexed—lung cancer	0.00028	0.00273	CcSEcCtD
Isoniazid—Neuropathy peripheral—Cisplatin—lung cancer	0.000278	0.00272	CcSEcCtD
Isoniazid—Nausea—Gefitinib—lung cancer	0.000278	0.00272	CcSEcCtD
Isoniazid—Anorexia—Vinblastine—lung cancer	0.000277	0.00271	CcSEcCtD
Isoniazid—Thrombocytopenia—Topotecan—lung cancer	0.000277	0.0027	CcSEcCtD
Isoniazid—Ill-defined disorder—Vinorelbine—lung cancer	0.000275	0.00269	CcSEcCtD
Isoniazid—Thrombocytopenia—Erlotinib—lung cancer	0.000274	0.00268	CcSEcCtD
Isoniazid—Asthenia—Teniposide—lung cancer	0.000273	0.00267	CcSEcCtD
Isoniazid—Anorexia—Topotecan—lung cancer	0.000269	0.00263	CcSEcCtD
Isoniazid—Malaise—Vinorelbine—lung cancer	0.000267	0.00261	CcSEcCtD
Isoniazid—Anorexia—Erlotinib—lung cancer	0.000266	0.00261	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Doxorubicin—lung cancer	0.000265	0.00259	CcSEcCtD
Isoniazid—Aplastic anaemia—Methotrexate—lung cancer	0.000261	0.00256	CcSEcCtD
Isoniazid—Paraesthesia—Vinblastine—lung cancer	0.000261	0.00255	CcSEcCtD
Isoniazid—Hyperglycaemia—Paclitaxel—lung cancer	0.000258	0.00252	CcSEcCtD
Isoniazid—Neuropathy peripheral—Etoposide—lung cancer	0.000255	0.00249	CcSEcCtD
Isoniazid—Paraesthesia—Topotecan—lung cancer	0.000254	0.00248	CcSEcCtD
Isoniazid—Jaundice—Etoposide—lung cancer	0.000253	0.00248	CcSEcCtD
Isoniazid—Decreased appetite—Vinblastine—lung cancer	0.000253	0.00247	CcSEcCtD
Isoniazid—Neuropathy peripheral—Paclitaxel—lung cancer	0.00025	0.00244	CcSEcCtD
Isoniazid—Discomfort—Vinorelbine—lung cancer	0.000249	0.00244	CcSEcCtD
Isoniazid—Gynaecomastia—Methotrexate—lung cancer	0.000249	0.00244	CcSEcCtD
Isoniazid—Dyspepsia—Topotecan—lung cancer	0.000249	0.00243	CcSEcCtD
Isoniazid—Dyspepsia—Erlotinib—lung cancer	0.000246	0.00241	CcSEcCtD
Isoniazid—Decreased appetite—Topotecan—lung cancer	0.000246	0.0024	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Topotecan—lung cancer	0.000244	0.00239	CcSEcCtD
Isoniazid—Fatigue—Topotecan—lung cancer	0.000244	0.00238	CcSEcCtD
Isoniazid—Decreased appetite—Erlotinib—lung cancer	0.000243	0.00238	CcSEcCtD
Isoniazid—Agranulocytosis—Etoposide—lung cancer	0.000243	0.00237	CcSEcCtD
Isoniazid—Vomiting—Teniposide—lung cancer	0.000242	0.00237	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Erlotinib—lung cancer	0.000241	0.00236	CcSEcCtD
Isoniazid—Hepatocellular injury—Doxorubicin—lung cancer	0.000241	0.00236	CcSEcCtD
Isoniazid—Fatigue—Erlotinib—lung cancer	0.000241	0.00236	CcSEcCtD
Isoniazid—Rash—Teniposide—lung cancer	0.00024	0.00235	CcSEcCtD
Isoniazid—Feeling abnormal—Vinblastine—lung cancer	0.00024	0.00234	CcSEcCtD
Isoniazid—Lymphadenopathy—Methotrexate—lung cancer	0.000237	0.00232	CcSEcCtD
Isoniazid—Thrombocytopenia—Vinorelbine—lung cancer	0.000237	0.00231	CcSEcCtD
Isoniazid—Feeling abnormal—Topotecan—lung cancer	0.000233	0.00228	CcSEcCtD
Isoniazid—Diabetes mellitus—Methotrexate—lung cancer	0.000232	0.00227	CcSEcCtD
Isoniazid—Anorexia—Vinorelbine—lung cancer	0.00023	0.00225	CcSEcCtD
Isoniazid—Ill-defined disorder—Irinotecan—lung cancer	0.000227	0.00222	CcSEcCtD
Isoniazid—Nausea—Teniposide—lung cancer	0.000226	0.00221	CcSEcCtD
Isoniazid—Aplastic anaemia—Doxorubicin—lung cancer	0.000226	0.00221	CcSEcCtD
Isoniazid—Body temperature increased—Topotecan—lung cancer	0.000223	0.00218	CcSEcCtD
Isoniazid—Body temperature increased—Erlotinib—lung cancer	0.000221	0.00216	CcSEcCtD
Isoniazid—Ill-defined disorder—Gemcitabine—lung cancer	0.000221	0.00216	CcSEcCtD
Isoniazid—Malaise—Irinotecan—lung cancer	0.00022	0.00215	CcSEcCtD
Isoniazid—Paraesthesia—Vinorelbine—lung cancer	0.000217	0.00212	CcSEcCtD
Isoniazid—Malaise—Gemcitabine—lung cancer	0.000215	0.0021	CcSEcCtD
Isoniazid—Hypersensitivity—Vinblastine—lung cancer	0.000214	0.0021	CcSEcCtD
Isoniazid—Neuropathy peripheral—Docetaxel—lung cancer	0.000212	0.00207	CcSEcCtD
Isoniazid—Jaundice—Docetaxel—lung cancer	0.000211	0.00206	CcSEcCtD
Isoniazid—Decreased appetite—Vinorelbine—lung cancer	0.00021	0.00205	CcSEcCtD
Isoniazid—Asthenia—Vinblastine—lung cancer	0.000209	0.00204	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000209	0.00204	CcSEcCtD
Isoniazid—Fatigue—Vinorelbine—lung cancer	0.000208	0.00204	CcSEcCtD
Isoniazid—Hypersensitivity—Topotecan—lung cancer	0.000208	0.00204	CcSEcCtD
Isoniazid—Ill-defined disorder—Cisplatin—lung cancer	0.000206	0.00201	CcSEcCtD
Isoniazid—Discomfort—Irinotecan—lung cancer	0.000205	0.00201	CcSEcCtD
Isoniazid—Lymphadenopathy—Doxorubicin—lung cancer	0.000205	0.00201	CcSEcCtD
Isoniazid—Asthenia—Topotecan—lung cancer	0.000203	0.00198	CcSEcCtD
Isoniazid—Agranulocytosis—Docetaxel—lung cancer	0.000202	0.00197	CcSEcCtD
Isoniazid—Diabetes mellitus—Doxorubicin—lung cancer	0.000201	0.00197	CcSEcCtD
Isoniazid—Asthenia—Erlotinib—lung cancer	0.000201	0.00196	CcSEcCtD
Isoniazid—Hepatic function abnormal—Doxorubicin—lung cancer	0.0002	0.00196	CcSEcCtD
Isoniazid—Discomfort—Gemcitabine—lung cancer	0.0002	0.00196	CcSEcCtD
Isoniazid—Malaise—Cisplatin—lung cancer	0.0002	0.00196	CcSEcCtD
Isoniazid—Feeling abnormal—Vinorelbine—lung cancer	0.000199	0.00195	CcSEcCtD
Isoniazid—Thrombocytopenia—Irinotecan—lung cancer	0.000195	0.00191	CcSEcCtD
Isoniazid—Hepatitis—Docetaxel—lung cancer	0.000194	0.0019	CcSEcCtD
Isoniazid—Convulsion—Cisplatin—lung cancer	0.000192	0.00188	CcSEcCtD
Isoniazid—Body temperature increased—Vinorelbine—lung cancer	0.000191	0.00187	CcSEcCtD
Isoniazid—Thrombocytopenia—Gemcitabine—lung cancer	0.00019	0.00186	CcSEcCtD
Isoniazid—Anorexia—Irinotecan—lung cancer	0.00019	0.00186	CcSEcCtD
Isoniazid—Ill-defined disorder—Etoposide—lung cancer	0.000188	0.00184	CcSEcCtD
Isoniazid—Discomfort—Cisplatin—lung cancer	0.000187	0.00182	CcSEcCtD
Isoniazid—Anorexia—Gemcitabine—lung cancer	0.000185	0.00181	CcSEcCtD
Isoniazid—Vomiting—Vinblastine—lung cancer	0.000185	0.00181	CcSEcCtD
Isoniazid—Ill-defined disorder—Paclitaxel—lung cancer	0.000185	0.00181	CcSEcCtD
Isoniazid—Malaise—Etoposide—lung cancer	0.000183	0.00179	CcSEcCtD
Isoniazid—Vomiting—Topotecan—lung cancer	0.00018	0.00176	CcSEcCtD
Isoniazid—Malaise—Paclitaxel—lung cancer	0.00018	0.00176	CcSEcCtD
Isoniazid—Paraesthesia—Irinotecan—lung cancer	0.000179	0.00175	CcSEcCtD
Isoniazid—Rash—Topotecan—lung cancer	0.000178	0.00174	CcSEcCtD
Isoniazid—Hypersensitivity—Vinorelbine—lung cancer	0.000178	0.00174	CcSEcCtD
Isoniazid—Vomiting—Erlotinib—lung cancer	0.000178	0.00174	CcSEcCtD
Isoniazid—Thrombocytopenia—Cisplatin—lung cancer	0.000177	0.00173	CcSEcCtD
Isoniazid—Rash—Erlotinib—lung cancer	0.000176	0.00172	CcSEcCtD
Isoniazid—Convulsion—Etoposide—lung cancer	0.000176	0.00172	CcSEcCtD
Isoniazid—Dyspepsia—Irinotecan—lung cancer	0.000175	0.00172	CcSEcCtD
Isoniazid—Paraesthesia—Gemcitabine—lung cancer	0.000174	0.0017	CcSEcCtD
Isoniazid—Asthenia—Vinorelbine—lung cancer	0.000173	0.0017	CcSEcCtD
Isoniazid—Decreased appetite—Irinotecan—lung cancer	0.000173	0.00169	CcSEcCtD
Isoniazid—Eosinophilia—Methotrexate—lung cancer	0.000173	0.00169	CcSEcCtD
Isoniazid—Nausea—Vinblastine—lung cancer	0.000173	0.00169	CcSEcCtD
Isoniazid—Convulsion—Paclitaxel—lung cancer	0.000173	0.00169	CcSEcCtD
Isoniazid—Anorexia—Cisplatin—lung cancer	0.000172	0.00169	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Irinotecan—lung cancer	0.000172	0.00168	CcSEcCtD
Isoniazid—Fatigue—Irinotecan—lung cancer	0.000172	0.00168	CcSEcCtD
Isoniazid—Discomfort—Etoposide—lung cancer	0.000171	0.00167	CcSEcCtD
Isoniazid—Decreased appetite—Gemcitabine—lung cancer	0.000169	0.00165	CcSEcCtD
Isoniazid—Nausea—Topotecan—lung cancer	0.000168	0.00164	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000168	0.00164	CcSEcCtD
Isoniazid—Discomfort—Paclitaxel—lung cancer	0.000168	0.00164	CcSEcCtD
Isoniazid—Fatigue—Gemcitabine—lung cancer	0.000167	0.00164	CcSEcCtD
Isoniazid—Nausea—Erlotinib—lung cancer	0.000166	0.00162	CcSEcCtD
Isoniazid—Feeling abnormal—Irinotecan—lung cancer	0.000164	0.00161	CcSEcCtD
Isoniazid—Paraesthesia—Cisplatin—lung cancer	0.000162	0.00159	CcSEcCtD
Isoniazid—Thrombocytopenia—Etoposide—lung cancer	0.000162	0.00159	CcSEcCtD
Isoniazid—Feeling abnormal—Gemcitabine—lung cancer	0.00016	0.00156	CcSEcCtD
Isoniazid—Thrombocytopenia—Paclitaxel—lung cancer	0.000159	0.00156	CcSEcCtD
Isoniazid—Anorexia—Etoposide—lung cancer	0.000158	0.00155	CcSEcCtD
Isoniazid—Body temperature increased—Irinotecan—lung cancer	0.000158	0.00154	CcSEcCtD
Isoniazid—Decreased appetite—Cisplatin—lung cancer	0.000157	0.00154	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Cisplatin—lung cancer	0.000156	0.00153	CcSEcCtD
Isoniazid—Anorexia—Paclitaxel—lung cancer	0.000155	0.00152	CcSEcCtD
Isoniazid—Vomiting—Vinorelbine—lung cancer	0.000154	0.0015	CcSEcCtD
Isoniazid—Body temperature increased—Gemcitabine—lung cancer	0.000153	0.0015	CcSEcCtD
Isoniazid—Rash—Vinorelbine—lung cancer	0.000152	0.00149	CcSEcCtD
Isoniazid—Eosinophilia—Doxorubicin—lung cancer	0.00015	0.00146	CcSEcCtD
Isoniazid—Feeling abnormal—Cisplatin—lung cancer	0.000149	0.00146	CcSEcCtD
Isoniazid—Paraesthesia—Etoposide—lung cancer	0.000149	0.00146	CcSEcCtD
Isoniazid—Hypersensitivity—Irinotecan—lung cancer	0.000147	0.00144	CcSEcCtD
Isoniazid—Convulsion—Docetaxel—lung cancer	0.000146	0.00143	CcSEcCtD
Isoniazid—Paraesthesia—Paclitaxel—lung cancer	0.000146	0.00143	CcSEcCtD
Isoniazid—Agranulocytosis—Methotrexate—lung cancer	0.000145	0.00142	CcSEcCtD
Isoniazid—Decreased appetite—Etoposide—lung cancer	0.000144	0.00141	CcSEcCtD
Isoniazid—Nausea—Vinorelbine—lung cancer	0.000144	0.0014	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Etoposide—lung cancer	0.000143	0.0014	CcSEcCtD
Isoniazid—Dyspepsia—Paclitaxel—lung cancer	0.000143	0.0014	CcSEcCtD
Isoniazid—Body temperature increased—Cisplatin—lung cancer	0.000143	0.0014	CcSEcCtD
Isoniazid—Asthenia—Irinotecan—lung cancer	0.000143	0.0014	CcSEcCtD
Isoniazid—Fatigue—Etoposide—lung cancer	0.000143	0.0014	CcSEcCtD
Isoniazid—Decreased appetite—Paclitaxel—lung cancer	0.000141	0.00138	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Paclitaxel—lung cancer	0.00014	0.00137	CcSEcCtD
Isoniazid—Fatigue—Paclitaxel—lung cancer	0.00014	0.00137	CcSEcCtD
Isoniazid—Hepatitis—Methotrexate—lung cancer	0.00014	0.00137	CcSEcCtD
Isoniazid—Asthenia—Gemcitabine—lung cancer	0.000139	0.00136	CcSEcCtD
Isoniazid—Feeling abnormal—Etoposide—lung cancer	0.000137	0.00134	CcSEcCtD
Isoniazid—Hyperglycaemia—Doxorubicin—lung cancer	0.000136	0.00133	CcSEcCtD
Isoniazid—Thrombocytopenia—Docetaxel—lung cancer	0.000135	0.00132	CcSEcCtD
Isoniazid—Feeling abnormal—Paclitaxel—lung cancer	0.000134	0.00131	CcSEcCtD
Isoniazid—Hypersensitivity—Cisplatin—lung cancer	0.000133	0.0013	CcSEcCtD
Isoniazid—Neuropathy peripheral—Doxorubicin—lung cancer	0.000132	0.00129	CcSEcCtD
Isoniazid—Jaundice—Doxorubicin—lung cancer	0.000131	0.00129	CcSEcCtD
Isoniazid—Anorexia—Docetaxel—lung cancer	0.000131	0.00128	CcSEcCtD
Isoniazid—Body temperature increased—Etoposide—lung cancer	0.000131	0.00128	CcSEcCtD
Isoniazid—Asthenia—Cisplatin—lung cancer	0.00013	0.00127	CcSEcCtD
Isoniazid—Body temperature increased—Paclitaxel—lung cancer	0.000128	0.00126	CcSEcCtD
Isoniazid—Vomiting—Irinotecan—lung cancer	0.000127	0.00124	CcSEcCtD
Isoniazid—Agranulocytosis—Doxorubicin—lung cancer	0.000126	0.00123	CcSEcCtD
Isoniazid—Rash—Irinotecan—lung cancer	0.000126	0.00123	CcSEcCtD
Isoniazid—Paraesthesia—Docetaxel—lung cancer	0.000124	0.00121	CcSEcCtD
Isoniazid—Vomiting—Gemcitabine—lung cancer	0.000123	0.00121	CcSEcCtD
Isoniazid—Rash—Gemcitabine—lung cancer	0.000122	0.0012	CcSEcCtD
Isoniazid—Hypersensitivity—Etoposide—lung cancer	0.000122	0.00119	CcSEcCtD
Isoniazid—Dyspepsia—Docetaxel—lung cancer	0.000121	0.00119	CcSEcCtD
Isoniazid—Hepatitis—Doxorubicin—lung cancer	0.000121	0.00118	CcSEcCtD
Isoniazid—Decreased appetite—Docetaxel—lung cancer	0.00012	0.00117	CcSEcCtD
Isoniazid—Hypersensitivity—Paclitaxel—lung cancer	0.00012	0.00117	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Docetaxel—lung cancer	0.000119	0.00116	CcSEcCtD
Isoniazid—Asthenia—Etoposide—lung cancer	0.000119	0.00116	CcSEcCtD
Isoniazid—Fatigue—Docetaxel—lung cancer	0.000119	0.00116	CcSEcCtD
Isoniazid—Nausea—Irinotecan—lung cancer	0.000118	0.00116	CcSEcCtD
Isoniazid—Asthenia—Paclitaxel—lung cancer	0.000117	0.00114	CcSEcCtD
Isoniazid—Nausea—Gemcitabine—lung cancer	0.000115	0.00113	CcSEcCtD
Isoniazid—Vomiting—Cisplatin—lung cancer	0.000115	0.00113	CcSEcCtD
Isoniazid—Rash—Cisplatin—lung cancer	0.000114	0.00112	CcSEcCtD
Isoniazid—Feeling abnormal—Docetaxel—lung cancer	0.000114	0.00111	CcSEcCtD
Isoniazid—Ill-defined disorder—Methotrexate—lung cancer	0.000113	0.0011	CcSEcCtD
Isoniazid—Malaise—Methotrexate—lung cancer	0.00011	0.00107	CcSEcCtD
Isoniazid—Body temperature increased—Docetaxel—lung cancer	0.000109	0.00107	CcSEcCtD
Isoniazid—Nausea—Cisplatin—lung cancer	0.000107	0.00105	CcSEcCtD
Isoniazid—Convulsion—Methotrexate—lung cancer	0.000105	0.00103	CcSEcCtD
Isoniazid—Vomiting—Etoposide—lung cancer	0.000105	0.00103	CcSEcCtD
Isoniazid—Rash—Etoposide—lung cancer	0.000105	0.00102	CcSEcCtD
Isoniazid—Vomiting—Paclitaxel—lung cancer	0.000103	0.00101	CcSEcCtD
Isoniazid—Rash—Paclitaxel—lung cancer	0.000102	0.001	CcSEcCtD
Isoniazid—Discomfort—Methotrexate—lung cancer	0.000102	0.001	CcSEcCtD
Isoniazid—Hypersensitivity—Docetaxel—lung cancer	0.000102	0.000993	CcSEcCtD
Isoniazid—Asthenia—Docetaxel—lung cancer	9.89e-05	0.000967	CcSEcCtD
Isoniazid—Nausea—Etoposide—lung cancer	9.85e-05	0.000963	CcSEcCtD
Isoniazid—Ill-defined disorder—Doxorubicin—lung cancer	9.78e-05	0.000956	CcSEcCtD
Isoniazid—Thrombocytopenia—Methotrexate—lung cancer	9.72e-05	0.000951	CcSEcCtD
Isoniazid—Nausea—Paclitaxel—lung cancer	9.66e-05	0.000944	CcSEcCtD
Isoniazid—Malaise—Doxorubicin—lung cancer	9.5e-05	0.000929	CcSEcCtD
Isoniazid—Anorexia—Methotrexate—lung cancer	9.47e-05	0.000926	CcSEcCtD
Isoniazid—Convulsion—Doxorubicin—lung cancer	9.13e-05	0.000893	CcSEcCtD
Isoniazid—Paraesthesia—Methotrexate—lung cancer	8.92e-05	0.000872	CcSEcCtD
Isoniazid—Discomfort—Doxorubicin—lung cancer	8.86e-05	0.000867	CcSEcCtD
Isoniazid—Vomiting—Docetaxel—lung cancer	8.76e-05	0.000857	CcSEcCtD
Isoniazid—Dyspepsia—Methotrexate—lung cancer	8.74e-05	0.000855	CcSEcCtD
Isoniazid—Rash—Docetaxel—lung cancer	8.69e-05	0.00085	CcSEcCtD
Isoniazid—Decreased appetite—Methotrexate—lung cancer	8.63e-05	0.000844	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Methotrexate—lung cancer	8.57e-05	0.000838	CcSEcCtD
Isoniazid—Fatigue—Methotrexate—lung cancer	8.56e-05	0.000837	CcSEcCtD
Isoniazid—Thrombocytopenia—Doxorubicin—lung cancer	8.42e-05	0.000823	CcSEcCtD
Isoniazid—Anorexia—Doxorubicin—lung cancer	8.2e-05	0.000802	CcSEcCtD
Isoniazid—Nausea—Docetaxel—lung cancer	8.18e-05	0.0008	CcSEcCtD
Isoniazid—Feeling abnormal—Methotrexate—lung cancer	8.18e-05	0.0008	CcSEcCtD
Isoniazid—Body temperature increased—Methotrexate—lung cancer	7.85e-05	0.000768	CcSEcCtD
Isoniazid—Paraesthesia—Doxorubicin—lung cancer	7.72e-05	0.000755	CcSEcCtD
Isoniazid—Dyspepsia—Doxorubicin—lung cancer	7.57e-05	0.00074	CcSEcCtD
Isoniazid—Decreased appetite—Doxorubicin—lung cancer	7.47e-05	0.000731	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Doxorubicin—lung cancer	7.42e-05	0.000726	CcSEcCtD
Isoniazid—Fatigue—Doxorubicin—lung cancer	7.41e-05	0.000725	CcSEcCtD
Isoniazid—Hypersensitivity—Methotrexate—lung cancer	7.32e-05	0.000715	CcSEcCtD
Isoniazid—Asthenia—Methotrexate—lung cancer	7.12e-05	0.000697	CcSEcCtD
Isoniazid—Feeling abnormal—Doxorubicin—lung cancer	7.09e-05	0.000693	CcSEcCtD
Isoniazid—Body temperature increased—Doxorubicin—lung cancer	6.8e-05	0.000665	CcSEcCtD
Isoniazid—Hypersensitivity—Doxorubicin—lung cancer	6.34e-05	0.00062	CcSEcCtD
Isoniazid—Vomiting—Methotrexate—lung cancer	6.31e-05	0.000617	CcSEcCtD
Isoniazid—Rash—Methotrexate—lung cancer	6.26e-05	0.000612	CcSEcCtD
Isoniazid—Asthenia—Doxorubicin—lung cancer	6.17e-05	0.000603	CcSEcCtD
Isoniazid—Nausea—Methotrexate—lung cancer	5.9e-05	0.000577	CcSEcCtD
Isoniazid—Vomiting—Doxorubicin—lung cancer	5.47e-05	0.000535	CcSEcCtD
Isoniazid—Rash—Doxorubicin—lung cancer	5.42e-05	0.00053	CcSEcCtD
Isoniazid—Nausea—Doxorubicin—lung cancer	5.11e-05	0.000499	CcSEcCtD
Isoniazid—CYP2E1—Metabolism—STK11—lung cancer	7.28e-06	7.81e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	7.26e-06	7.79e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—ADCY1—lung cancer	7.25e-06	7.78e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—ABCG2—lung cancer	7.25e-06	7.78e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—ABCG2—lung cancer	7.19e-06	7.71e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—ADCY1—lung cancer	7.19e-06	7.71e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—ENO2—lung cancer	7.11e-06	7.63e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—HPGDS—lung cancer	7.11e-06	7.63e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—UGT1A1—lung cancer	7.08e-06	7.6e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PPP2R1B—lung cancer	7.07e-06	7.58e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—CYP2E1—lung cancer	7.06e-06	7.57e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—ENO2—lung cancer	7.05e-06	7.56e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—HPGDS—lung cancer	7.05e-06	7.56e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—ENO1—lung cancer	7.03e-06	7.54e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PPP2R1B—lung cancer	7.01e-06	7.51e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	7e-06	7.51e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—NQO1—lung cancer	6.98e-06	7.49e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	6.91e-06	7.41e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	6.91e-06	7.41e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—GSTT1—lung cancer	6.9e-06	7.4e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—RRM1—lung cancer	6.84e-06	7.34e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GSTA3—lung cancer	6.84e-06	7.34e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—GSTT1—lung cancer	6.84e-06	7.33e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.84e-06	7.33e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GNG11—lung cancer	6.83e-06	7.33e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—GCLC—lung cancer	6.82e-06	7.31e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CYP2A6—lung cancer	6.82e-06	7.31e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	6.8e-06	7.29e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.77e-06	7.27e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CYP2A6—lung cancer	6.76e-06	7.25e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—GCLC—lung cancer	6.76e-06	7.25e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—GSTP1—lung cancer	6.74e-06	7.23e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	6.73e-06	7.22e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—CAT—lung cancer	6.56e-06	7.03e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ALDOA—lung cancer	6.5e-06	6.98e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—ENO1—lung cancer	6.46e-06	6.93e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—B4GALT5—lung cancer	6.43e-06	6.9e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—ENO1—lung cancer	6.41e-06	6.87e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	6.38e-06	6.85e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—ABCB1—lung cancer	6.38e-06	6.84e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—APOA1—lung cancer	6.37e-06	6.84e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—NCOA3—lung cancer	6.31e-06	6.77e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—CYP2E1—lung cancer	6.3e-06	6.76e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	6.3e-06	6.76e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—STK11—lung cancer	6.29e-06	6.75e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—TYMS—lung cancer	6.26e-06	6.72e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GSTA4—lung cancer	6.26e-06	6.71e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—NQO1—lung cancer	6.23e-06	6.69e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	6.21e-06	6.66e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—GSTM1—lung cancer	6.19e-06	6.64e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ADCY1—lung cancer	6.14e-06	6.59e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ABCG2—lung cancer	6.14e-06	6.59e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.1e-06	6.55e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GSTA2—lung cancer	6.1e-06	6.54e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.05e-06	6.49e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—HPGDS—lung cancer	6.02e-06	6.46e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ENO2—lung cancer	6.02e-06	6.46e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PPP2R1B—lung cancer	5.99e-06	6.42e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.91e-06	6.34e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	5.91e-06	6.34e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GSTA1—lung cancer	5.88e-06	6.31e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—CYP1A1—lung cancer	5.87e-06	6.3e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GSTT1—lung cancer	5.84e-06	6.27e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—GSTP1—lung cancer	5.82e-06	6.25e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—ERCC2—lung cancer	5.82e-06	6.24e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PIK3CG—lung cancer	5.82e-06	6.24e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ABCC3—lung cancer	5.82e-06	6.24e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CYP2E1—lung cancer	5.8e-06	6.22e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CYP2A6—lung cancer	5.78e-06	6.2e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GCLC—lung cancer	5.78e-06	6.2e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	5.75e-06	6.17e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CYP2E1—lung cancer	5.75e-06	6.16e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—NQO1—lung cancer	5.73e-06	6.15e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—NQO1—lung cancer	5.68e-06	6.1e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—CAT—lung cancer	5.67e-06	6.08e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.63e-06	6.04e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—AKR1C1—lung cancer	5.63e-06	6.04e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—STK11—lung cancer	5.62e-06	6.03e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.56e-06	5.97e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—POMC—lung cancer	5.54e-06	5.94e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.51e-06	5.91e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—ABCB1—lung cancer	5.51e-06	5.91e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ENO1—lung cancer	5.48e-06	5.87e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—UGT1A1—lung cancer	5.47e-06	5.87e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	5.46e-06	5.85e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—TYMS—lung cancer	5.41e-06	5.81e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—CREBBP—lung cancer	5.39e-06	5.79e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	5.39e-06	5.78e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—GSTM1—lung cancer	5.35e-06	5.74e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.27e-06	5.66e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GNG11—lung cancer	5.27e-06	5.66e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—GSTP1—lung cancer	5.2e-06	5.58e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—STK11—lung cancer	5.17e-06	5.54e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—STK11—lung cancer	5.12e-06	5.49e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PIK3CD—lung cancer	5.11e-06	5.49e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—CYP1A1—lung cancer	5.07e-06	5.44e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—CAT—lung cancer	5.06e-06	5.43e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—ALB—lung cancer	5.05e-06	5.42e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—APOA1—lung cancer	5.04e-06	5.4e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—ERCC2—lung cancer	5.03e-06	5.4e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.03e-06	5.39e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ALDOA—lung cancer	5.02e-06	5.39e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—ABCB1—lung cancer	4.92e-06	5.28e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CYP2E1—lung cancer	4.91e-06	5.27e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—NCOA3—lung cancer	4.87e-06	5.23e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—NQO1—lung cancer	4.86e-06	5.21e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—TYMS—lung cancer	4.83e-06	5.18e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.81e-06	5.16e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—GSTP1—lung cancer	4.78e-06	5.13e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—GSTM1—lung cancer	4.78e-06	5.12e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.75e-06	5.1e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ABCG2—lung cancer	4.74e-06	5.09e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ADCY1—lung cancer	4.74e-06	5.09e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—GSTP1—lung cancer	4.74e-06	5.08e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.71e-06	5.05e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CAT—lung cancer	4.65e-06	4.99e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—HPGDS—lung cancer	4.65e-06	4.99e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ENO2—lung cancer	4.65e-06	4.99e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PPP2R1B—lung cancer	4.62e-06	4.96e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CAT—lung cancer	4.61e-06	4.95e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PIK3CG—lung cancer	4.6e-06	4.93e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.59e-06	4.92e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—CYP1A1—lung cancer	4.53e-06	4.86e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—ABCB1—lung cancer	4.53e-06	4.85e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GSTT1—lung cancer	4.51e-06	4.84e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—ERCC2—lung cancer	4.49e-06	4.82e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—ABCB1—lung cancer	4.49e-06	4.81e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GCLC—lung cancer	4.46e-06	4.78e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CYP2A6—lung cancer	4.46e-06	4.78e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PIK3CB—lung cancer	4.46e-06	4.78e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—TYMS—lung cancer	4.44e-06	4.77e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PTGS2—lung cancer	4.42e-06	4.74e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—TYMS—lung cancer	4.41e-06	4.73e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—GSTM1—lung cancer	4.39e-06	4.71e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—STK11—lung cancer	4.38e-06	4.7e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—POMC—lung cancer	4.38e-06	4.69e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—GSTM1—lung cancer	4.36e-06	4.67e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—APOA1—lung cancer	4.35e-06	4.67e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—CREBBP—lung cancer	4.26e-06	4.57e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ENO1—lung cancer	4.23e-06	4.53e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.17e-06	4.47e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CYP1A1—lung cancer	4.16e-06	4.47e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—ERCC2—lung cancer	4.13e-06	4.43e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CYP1A1—lung cancer	4.13e-06	4.43e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.11e-06	4.41e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—ERCC2—lung cancer	4.09e-06	4.39e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GSTP1—lung cancer	4.05e-06	4.34e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PIK3CD—lung cancer	4.04e-06	4.34e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—ALB—lung cancer	3.99e-06	4.28e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PIK3CG—lung cancer	3.97e-06	4.26e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CAT—lung cancer	3.94e-06	4.23e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.92e-06	4.2e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—APOA1—lung cancer	3.88e-06	4.17e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PTEN—lung cancer	3.85e-06	4.13e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ABCB1—lung cancer	3.83e-06	4.11e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CYP2E1—lung cancer	3.79e-06	4.07e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—POMC—lung cancer	3.78e-06	4.06e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—TYMS—lung cancer	3.77e-06	4.04e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—NQO1—lung cancer	3.75e-06	4.02e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GSTM1—lung cancer	3.72e-06	3.99e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.72e-06	3.99e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—CREBBP—lung cancer	3.68e-06	3.95e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—EP300—lung cancer	3.67e-06	3.94e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—APOA1—lung cancer	3.57e-06	3.83e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PIK3CG—lung cancer	3.55e-06	3.8e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—APOA1—lung cancer	3.54e-06	3.8e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CYP1A1—lung cancer	3.53e-06	3.78e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PIK3CB—lung cancer	3.52e-06	3.78e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ERCC2—lung cancer	3.5e-06	3.75e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PIK3CD—lung cancer	3.49e-06	3.75e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PTGS2—lung cancer	3.49e-06	3.74e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—ALB—lung cancer	3.45e-06	3.7e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.39e-06	3.64e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—STK11—lung cancer	3.38e-06	3.62e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—POMC—lung cancer	3.38e-06	3.62e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—CREBBP—lung cancer	3.29e-06	3.53e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PIK3CG—lung cancer	3.26e-06	3.5e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PIK3CG—lung cancer	3.23e-06	3.47e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GSTP1—lung cancer	3.13e-06	3.35e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PIK3CD—lung cancer	3.12e-06	3.34e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—POMC—lung cancer	3.11e-06	3.33e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—POMC—lung cancer	3.08e-06	3.3e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—ALB—lung cancer	3.08e-06	3.3e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PIK3CB—lung cancer	3.04e-06	3.27e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PTEN—lung cancer	3.04e-06	3.27e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CAT—lung cancer	3.04e-06	3.26e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—APOA1—lung cancer	3.03e-06	3.25e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CREBBP—lung cancer	3.02e-06	3.24e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PTGS2—lung cancer	3.02e-06	3.24e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CREBBP—lung cancer	3e-06	3.22e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ABCB1—lung cancer	2.96e-06	3.17e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—TYMS—lung cancer	2.91e-06	3.12e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—EP300—lung cancer	2.9e-06	3.11e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.9e-06	3.11e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GSTM1—lung cancer	2.87e-06	3.08e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PIK3CD—lung cancer	2.87e-06	3.08e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PIK3CD—lung cancer	2.84e-06	3.05e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—ALB—lung cancer	2.83e-06	3.04e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—ALB—lung cancer	2.81e-06	3.01e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PIK3CG—lung cancer	2.76e-06	2.96e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CYP1A1—lung cancer	2.72e-06	2.92e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PIK3CB—lung cancer	2.72e-06	2.92e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PIK3CA—lung cancer	2.72e-06	2.91e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ERCC2—lung cancer	2.7e-06	2.9e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PTGS2—lung cancer	2.69e-06	2.89e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PTEN—lung cancer	2.63e-06	2.82e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—POMC—lung cancer	2.63e-06	2.82e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CREBBP—lung cancer	2.56e-06	2.75e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—EP300—lung cancer	2.51e-06	2.69e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PIK3CB—lung cancer	2.5e-06	2.68e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PIK3CB—lung cancer	2.48e-06	2.66e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PTGS2—lung cancer	2.48e-06	2.66e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PTGS2—lung cancer	2.46e-06	2.63e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PIK3CD—lung cancer	2.43e-06	2.61e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ALB—lung cancer	2.4e-06	2.57e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PTEN—lung cancer	2.35e-06	2.52e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—APOA1—lung cancer	2.34e-06	2.51e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—EP300—lung cancer	2.24e-06	2.4e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—AKT1—lung cancer	2.22e-06	2.38e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PTEN—lung cancer	2.16e-06	2.32e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PIK3CA—lung cancer	2.15e-06	2.3e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PTEN—lung cancer	2.14e-06	2.3e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PIK3CG—lung cancer	2.13e-06	2.29e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PIK3CB—lung cancer	2.12e-06	2.27e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PTGS2—lung cancer	2.1e-06	2.25e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—EP300—lung cancer	2.06e-06	2.21e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—EP300—lung cancer	2.04e-06	2.19e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—POMC—lung cancer	2.03e-06	2.18e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CREBBP—lung cancer	1.98e-06	2.12e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PIK3CD—lung cancer	1.87e-06	2.01e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PIK3CA—lung cancer	1.86e-06	1.99e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ALB—lung cancer	1.85e-06	1.99e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PTEN—lung cancer	1.83e-06	1.96e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—AKT1—lung cancer	1.75e-06	1.88e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—EP300—lung cancer	1.75e-06	1.87e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PIK3CA—lung cancer	1.66e-06	1.78e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PIK3CB—lung cancer	1.63e-06	1.75e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PTGS2—lung cancer	1.62e-06	1.74e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PIK3CA—lung cancer	1.52e-06	1.63e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—AKT1—lung cancer	1.52e-06	1.63e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PIK3CA—lung cancer	1.51e-06	1.62e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PTEN—lung cancer	1.41e-06	1.51e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—AKT1—lung cancer	1.35e-06	1.45e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—EP300—lung cancer	1.35e-06	1.44e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PIK3CA—lung cancer	1.29e-06	1.38e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—AKT1—lung cancer	1.24e-06	1.34e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—AKT1—lung cancer	1.23e-06	1.32e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—AKT1—lung cancer	1.05e-06	1.13e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PIK3CA—lung cancer	9.96e-07	1.07e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—AKT1—lung cancer	8.14e-07	8.73e-06	CbGpPWpGaD
